This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

(Circulation. 2004;110:363.)
© 2004 American Heart Association, Inc.

Issue Highlights

An extract of the first 250 words of the full text is provided, because this article has no abstract.

FISH INTAKE AND RISK OF INCIDENT ATRIAL FIBRILLATION, by Mozaffarian et al.

Atrial fibrillation (AF) is a common rhythm disturbance that affects approximately 5% of the adult population. Although several contemporary studies have examined two major management strategies when AF occurs—rhythm control versus rate control—clinicians and patients are also interested in strategies that may prevent AF. In this report from the Cardiovascular Health Study, 4185 subjects 65 had their dietary habits assessed in 1989–1990 and were then monitored for the development of AF (detected on ECG or noted on hospital discharge summaries). Those subjects who ate tuna or broiled/baked fish had a significantly lower risk of the development of AF, and there appeared to be a dose response with greater rates of consumption associated with lower risk of AF. Fried fish or fish burgers were not protective. The electrophysiological mechanism of the beneficial effect of consumption of certain types of fish bears further investigation. See p 368.

TREATMENT OF LEFT ANTERIOR DESCENDING CORONARY ARTERY DISEASE WITH SIROLIMUS-ELUTING STENTS, by Sawhney et al.

The decision to pursue a percutaneous or surgical revascularization strategy often hinges on the presence of left anterior descending (LAD) coronary artery disease; coronary artery bypass surgery with a mammary artery conduit to the proximal LAD is often selected as the treatment option of choice because of a reduction in the need for repeat revascularization procedures from restenosis. In this subgroup analysis of the Sirolimus-Eluting Balloon-Expandable Stents in the Treatment of Patients with de novo Native Coronary Artery Lesions (SIRIUS) trial, outcomes in patients with LAD lesions, who were randomized to a sirolimus-eluting or bare-metal stent, were examined. Compared with patients treated with a bare-metal . . . [Full Text of this Article]